1. Patanè S. Cardiotoxicity: cisplatin and long-term cancer survivors. Int J Cardiol 2014; 1 75(1): 201-202.
2. Rocha CRR, Silva MM, Quinet A, et al. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics (Sao Paulo) 2018; 73(suppl 1): e478s. doi: 10.6061/clinics/2018/e478s.
3. de Jongh FE, van Veen RN, Veltman SJ, et al. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer 2003; 88(8): 1199-1206.
4. Uehara T, Yamate J, Torii M, et al. Comparative nephrotoxicity of cisplatin and nedaplatin: mechanisms and histopathological characteristics. J Toxicol Pathol 2011; 24(2): 87-94.
5. Xing JJ, Hou JG, Liu Y, et al. Supplementation of saponins from leaves of Panax quinquefolius mitigates cisplatin-evoked cardiotoxicity via inhibiting oxidative stress-associated inflammation and apoptosis in mice [Portuguese]. Antioxidants (Basel) 2019; 8(9): 347. doi: 10.3390/antiox8090347.
6. Peres LA, da Cunha AD Jr. Acute nephrotoxicity of cisplatin: molecular mechanisms. J Bras Nefrol 2013; 35(4): 332-340.
7. Tanyeli TT, Karadaş H, Akyıldız İ, et al. Effect of folic acid on cisplatin-induced ototoxicity: a functional and morphological study. J Int Adv Otol 2019; 15(2): 237-246.
8. Bleich S, Degner D, Sperling W, et al. Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsycho-pharmacol Biol Psychiatry 2004; 28(3): 453-464.
9. Craig SA. Betaine in human nutrition. Am J Clin Nutr 2004; 80(3): 539-549.
10. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 2012; 14(6): 542-555.
11. Sakamoto A, Nishimura Y, Ono H, et al. Betaine and homocysteine concentrations in foods. Pediatr Int 2002; 44(4): 409-413.
12. Alirezaei M, Jelodar G, Niknam P, et al. Betaine prevents ethanol-induced oxidative stress and reduces total homocysteine in the rat cerebellum. J Physiol Biochem 2011; 67(4): 605-612.
13. al-Hafyan S, Asoodeh A, Baghshani H, et al. Ameliorative potential of betaine against arsenite-induced hepatotoxicity and nephrotoxicity. Com Clin Pathol 2024; 33(1): 155-162.
14. Jung YS, Kim SJ, Kwon DY, et al. Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism. Food Chem Toxicol 2013; 62: 292-298.
15. Day CR, Kempson SA. Betaine chemistry, roles, and potential use in liver disease. Biochim Biophys Acta 2016; 1860(6): 1098-1106.
16. Barak AJ, Beckenhauer HC, Tuma DJ. Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol 2002; 26(2): 65-67.
17. Hussein RM, Al-Dalain SM. Betaine downregulates microRNA 34a expression via a p53-dependent manner in cisplatin-induced nephrotoxicity in rats. J Biochem Mol Toxicol 2021; 35(9): e22856. doi: 10.1002/jbt.22856.
18. Fu Y, Cai J, Li F, et al. Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells. Am J Physiol Renal Physiol 2019; 317(6): F1582-F1592.
19. Ülger M, Ülger B, Turan IT, et al. Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: an experimental study. Food Chem Toxicol 2025; 196: 115235. doi: 10.1016/j.fct.2025.115235.
20. Zhao G, He F, Wu C, et al. Betaine in inflammation: mechanistic aspects and applications. Front Immunol 2018; 9: 1070. doi: 10.3389/fimmu.2018.01070.
21. Oun R, Rowan E. Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node? Eur J Pharmacol 2017; 811: 125-128.
22. Talley RW, O'Bryan RM, Gutterman JU, et al. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study. Cancer Chemother Rep 1973; 57(4): 465-471.
23. Licciardello JT, Moake JL, Rudy CK, et al. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42(5): 296-300.
24. Xia J, Hu JN, Zhang RB, et al. Icariin exhibits protective effects on cisplatin-induced cardiotoxicity via ROS-mediated oxidative stress injury in vivo and in vitro. Phytomedicine 2022; 104:1 54331. doi: 10.1016/j.phymed.2022.154331.
25. Domingo IK, Latif A, Bhavsar AP. Pro-inflammatory signalling PRRopels cisplatin-induced toxicity. Int J Mol Sci 2022; 23(13): 7227. doi: 10.3390/ijms23137227.
26. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140(6): 805-820.
27. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical Microbiol Rev 2009; 22(2): 240-273.
28. Germolec DR, Shipkowski KA, Frawley RP, et al. Markers of inflammation. Methods Mol Biol 2018; 1803: 57-79.
29. Said RS, Mantawy EM, El-Demerdash E. Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Naunyn Schmiedebergs Arch Pharmacol 2019; 392(10):1225-1238.
30. Hamad R, Jayakumar C, Ranganathan P, et al. Honey feeding protects kidney against cisplatin nephrotoxicity through suppression of inflammation. Clin Exp Pharmacol Physiol 2015; 42(8): 843-848.
31. Kumar P, Sulakhiya K, Barua CC, et al. TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats. Mol Cell Biochem 2017; 431(1-2): 113-122.
32. Hagar H, Medany AE, Salam R, et al. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Exp Toxicol Pathol 2015; 67(2): 133-141.
33. Al Za'abi M, Ali H, Al Sabahi M, et al. The salutary action of melatonin and betaine, given singly or concomitantly, on cisplatin-induced nephrotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol 2021; 394(8): 1693-1701.
34. Freitas I, Boncompagni E, Tarantola E, et al. In situ evaluation of oxidative stress in rat fatty liver induced by a methionine- and choline-deficient diet. Oxid Med Cell Longev 2016; 2016: 9307064. doi: 10.1155/2016/9307064.
35. Chowdhury S, Sinha K, Banerjee S, et al. Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses. Biofactors 2016; 42(6): 647-664.
36. Ma X, Yan L, Zhu Q, et al. Puerarin attenuates cisplatin-induced rat nephrotoxicity: the involvement of TLR4/NF-κB signaling pathway. PLoS One 2017; 12(2): e0171612. doi: 10.1371/journal.pone.0171612.
37. Qi L, Luo Q, Zhang Y, et al. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol 2019; 32(8): 1469-1486.
38. Bahadır A, Ceyhan A, Öz Gergin Ö, et al. Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: an experimental rat model. Anatol J Cardiol 2018; 19(3): 213-221.
39. Ibrahim MA, Bakhaat GA, Tammam HG, et al. Cardioprotective effect of green tea extract and vitamin E on cisplatin-induced cardiotoxicity in mice: toxicological, histological and immunohistochemical studies. Biomed Pharmacother 2019; 113: 108731. doi: 10.1016/j.biopha.2019.108731.
40. Rosic G, Selakovic D, Joksimovic J, et al. The effects of N-acetylcysteine on cisplatin-induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts. Toxicol Lett 2016; 242: 34-46.
41. Erfani Majd N, Shahraki R, Tabandeh MR, et al. Protective effects of Aloe vera gel on cisplatin-induced oxidative stress, apoptosis and neurons structure in rat hippocampus. Vet Res Forum 2022; 13(1): 111-119.
42. Oliveira CA, Mercês ÉAB, Portela FS, et al. An integrated view of cisplatin-induced nephrotoxicity, hepato-toxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management. Clin Exp Nephrol 2024; 28(8): 711-727.
43. Almashhadany A, Shackebaei D, Van der Touw T, et al. Homocysteine exposure impairs myocardial resistance to ischaemia reperfusion and oxidative stress. Cell Physiol Biochem 2015; 37(6): 2265-2274.
44. Baggott JE, Tamura T. Homocysteine, iron and cardiovascular disease: a hypothesis. Nutrients 2015; 7(2): 1108-1118.
45. Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules 2015; 5(3): 1266-1283.
46. Hagar H, Husain S, Fadda LM, et al. Inhibition of NF-κB and the oxidative stress-dependent caspase-3 apoptotic pathway by betaine supplementation attenuates hepatic injury mediated by cisplatin in rats. Pharmacol Rep 2019; 71(6): 1025-1033.
47. Ashtary-Larky D, Bagheri R, Ghanavati M, et al. Effects of betaine supplementation on cardiovascular markers: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022; 62(23): 6516-6533.
48. Mukhopadhyay P, Horváth B, Zsengellér Z, et al. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 2012; 52(2): 497-506.
49. Shariati S, Shirani M, Azadnasab R, et al. Betaine protects mice from cardiotoxicity triggered by sodium arsenite through antioxidative and anti-inflammatory pathways. Cardiovasc Toxicol 2024; 24(6): 539-549.
50. Patel D, Yadav P, Singh SK, et al. Betaine alleviates doxorubicin-induced nephrotoxicity by preventing oxidative insults, inflammation, and fibrosis through the modulation of Nrf2/HO-1/NLRP3 and TGF-β expression. J Biochem Mol Toxicol 2024; 38(1): e23559. doi: 10.1002/jbt.23559.
